Johan Zebib joins Jim Cahill in an Emerson Automation Experts podcast to share how MES addresses many of the challenges for higher quality, and more efficient and reliable production in the pharmaceutical & biopharmaceutical manufacturing industries.
The life sciences industry is changing rapidly. Where once companies were focused on developing blockbuster treatments and manufacturing them as quickly and safely as possible, today, personalized medicine has changed that landscape. Now life sciences companies are...
As the landscape of pharmaceutical manufacturing has changed in the last few years, one exciting shift has a distinct possibility of being a game changer in coming decades. Regulatory agencies have increasingly begun to recognize the importance of automation...
There’s no question that today’s life sciences landscape is changing dramatically. As new personalized medicine solutions emerge, companies are rapidly changing scale to include more multi-product manufacturing facilities. Many of these facilities are manufacturing...
To know where you’re going, you have to know where you are, and operating a life sciences manufacturing facility is no exception. Pharmaceutical processors regularly have to take stock of their technological capacity to keep a finger on the pulse of the four main...
In just the last 10 years, biopharmaceutical supply chains have changed dramatically. The single-source manufacturing model is becoming much rarer, making way for multi-enterprise manufacturing collaborations and partnerships to better meet the changing needs of the...
The days of maintaining paper records across the life sciences development and production pipeline are gone. Today’s regulatory requirements, not to mention the complexity of new treatments, requires organization that can only be provided electronically. However,...
The life sciences marketplace is changing faster than nearly any other industry. Gone are the days when companies focus on a single treatment to drive their entire business. Today’s life sciences manufacturers are challenged to bring new treatments to the marketplace...
With registration now open for the October 24-28, 2022 Emerson Exchange conference in the Dallas, Texas area, I wanted to make sure you were aware that the Session Catalog is available for viewing.
In BioPhorum’s MES of the Future Manifesto, Sean and Kate Porter collaborated with other biomanufacturing leaders on requirements for future Manufacturing Execution Systems.
In an Australasian BioTechnology article, Facilities for a Strong Future, Emerson’s Michalle Adkins and Makarand Mujumdar share how pharmaceutical and biotech manufacturers can improve local capacity to meet the needs of the regions in which they operate.
There are four core pillars we look to address in order to support pharmaceutical and biopharmaceutical manufacturers in achieving line and facility efficiency goals.
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to stay up to date on the latest news, events and innovations that will help you face and solve your toughest challenges.
Just post a link to the entry and send us a quick note so we can share your work. Thank you very much.
Our Global Community
Emerson Exchange 365
The opinions expressed here are the personal opinions of the authors. Content published here is not read or approved by Emerson before it is posted and does not necessarily represent the views and opinions of Emerson.